These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 8675659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA.
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [Abstract] [Full Text] [Related]

  • 3. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B.
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
    Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM.
    J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057
    [Abstract] [Full Text] [Related]

  • 6. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM, La Du BN.
    J Clin Invest; 1997 Apr 15; 99(8):2005-19. PubMed ID: 9109446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.
    Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM.
    J Lipid Res; 2001 Aug 15; 42(8):1308-17. PubMed ID: 11483633
    [Abstract] [Full Text] [Related]

  • 12. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
    Leitinger N, Watson AD, Faull KF, Fogelman AM, Berliner JA.
    Adv Exp Med Biol; 1997 Aug 15; 433():379-82. PubMed ID: 9561175
    [Abstract] [Full Text] [Related]

  • 13. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
    Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 2007 Jun 15; 27(6):1346-53. PubMed ID: 17379837
    [Abstract] [Full Text] [Related]

  • 14. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN.
    J Clin Invest; 1998 Apr 15; 101(8):1581-90. PubMed ID: 9541487
    [Abstract] [Full Text] [Related]

  • 15. Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.
    Van Lenten BJ, Wagner AC, Navab M, Fogelman AM.
    J Biol Chem; 2001 Jan 19; 276(3):1923-9. PubMed ID: 11034996
    [Abstract] [Full Text] [Related]

  • 16. Oxidized LDL and HDL: antagonists in atherothrombosis.
    Mertens A, Holvoet P.
    FASEB J; 2001 Oct 19; 15(12):2073-84. PubMed ID: 11641234
    [Abstract] [Full Text] [Related]

  • 17. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
    Kimak E, Hałabiś M, Baranowicz-Gąszczyk I, Solski J, Książek A.
    J Zhejiang Univ Sci B; 2011 May 19; 12(5):365-71. PubMed ID: 21528490
    [Abstract] [Full Text] [Related]

  • 18. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
    Mastorikou M, Mackness M, Mackness B.
    Diabetes; 2006 Nov 19; 55(11):3099-103. PubMed ID: 17065348
    [Abstract] [Full Text] [Related]

  • 19. Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine.
    Ahmed Z, Babaei S, Maguire GF, Draganov D, Kuksis A, La Du BN, Connelly PW.
    Cardiovasc Res; 2003 Jan 19; 57(1):225-31. PubMed ID: 12504832
    [Abstract] [Full Text] [Related]

  • 20. Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.
    Reddy ST, Grijalva V, Ng C, Hassan K, Hama S, Mottahedeh R, Wadleigh DJ, Navab M, Fogelman AM.
    Vascul Pharmacol; 2002 Apr 19; 38(4):211-8. PubMed ID: 12449017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.